Somatoform Dissociation Questionnaire-5 (SDQ-5) Test

For readers who notice unexplained bodily sensations, altered perception, urinary pain, or difficulty speaking, the Somatoform Dissociation Questionnaire-5 (SDQ-5) Test offers a focused way to organize these experiences. This somatoform dissociation screening can show whether the pattern of reported symptoms falls in a lower or clinically significant range.

What This Assessment Explores

Rather than targeting a single complaint, the questionnaire samples bodily and perceptual experiences that may occur when ordinary body awareness or control feels disrupted. It is intended for people who want a structured first look at somatoform dissociation symptoms, especially experiences involving sensation, vision, bodily presence, and speech.

Together, these experiences allow the scale to summarize the severity and extent of reported somatoform dissociative symptoms. The Somatoform Dissociation Scale (SDQ-5) runs from 5-25: Low, 5-10; Clinically significant, 11-25. Higher totals reflect greater severity of bodily symptoms not explained by medical causes.

These are the main experience groups covered:

• Pain and sensory changes describe discomfort, numbness, or altered bodily sensitivity.
• Perceptual alterations indicate that vision or surroundings may feel unusually changed.
• Bodily presence and speech disruptions cover lost body awareness or difficulty speaking.

Methodology and Scientific Basis

Each self-report item uses a five-point response scale, moving from Not at all through graded intensity to Very strongly, Very much, or a comparable high-end option. The ordered responses are combined into a total that reflects the intensity endorsed across the five responses.

Methodologically, the online SDQ-5 questionnaire presents the five-item instrument described by Nijenhuis et al. (1997); no separate online validation is established. The related SDQ-20 development study provides broader construct and psychometric context, while Nijenhuis's 2010 scoring guidance addresses interpretation of both forms.

Evidence from Swedish versions concerns adolescents and young adults, so those findings should not be treated as norms for this online questionnaire. Published studies concern specific versions and samples; the online presentation does not establish separate norms for every reader. Because self-report is affected by current distress, self-awareness, and willingness to disclose, a clinically significant result is best treated as a prompt for broader evaluation rather than a standalone conclusion.